您的位置: 首页 > 资讯

EAACI to Launch World Anaphylaxis Awareness Day on 21 November at FAAM-EUROBAT 2024

2024-11-13 来源:European Academy of Allergy and Clinical Immunology

ATHENS, Greece, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI) is proud to announce the inaugural World Anaphylaxis Awareness Day on 21 November 2024. This landmark initiative, held on the opening day of FAAM-EUROBAT 2024 in Athens, Greece, seeks to raise awareness and promote essential steps in preventing and managing anaphylaxis, a severe, potentially life-threatening allergic reaction.

Anaphylaxis affects approximately 1-2% of the global population, with incidents on the rise worldwide. This severe allergic reaction demands immediate medical intervention and often stems from exposure to common allergens, including specific foods, insect stings, medications, or latex. Despite the risks, awareness of anaphylaxis symptoms, causes, and emergency responses remains low. World Anaphylaxis Awareness Day addresses these knowledge gaps and fosters a global understanding of this critical health issue.                                                   

Through various educational activities, World Anaphylaxis Awareness Day will underscore the importance of prompt emergency responses and preventive measures. EAACI invites medical professionals, allergy societies, and stakeholders worldwide to participate and amplify the message within their communities.

In conjunction with this day, EAACI will also release “A Practical Guide for Patients,” a comprehensive resource developed to support patients and caregivers in understanding, managing, and preventing anaphylactic reactions. This guide offers practical insights on identifying triggers, using adrenaline auto-injectors correctly, and creating personalised action plans to manage risk in everyday life.

“We are thrilled to launch World Anaphylaxis Awareness Day as part of FAAM-EUROBAT 2024,” said Dr Maria Torres, EAACI President. “With this initiative, we hope to empower individuals, families, and healthcare providers with the knowledge and tools to prevent and respond to anaphylaxis. This is an essential step toward improving patient care and reducing the impact of this serious health condition.”

FAAM-EUROBAT 2024, EAACI’s renowned Food Allergy and Anaphylaxis Meeting, will run from 21-23 November, featuring global leaders in allergy research and care. World Anaphylaxis Awareness Day will serve as a key moment within the conference to highlight EAACI’s commitment to patient safety and allergy awareness.

For more information on World Anaphylaxis Awareness Day or the “Practical Guide for Patients,” please visit EAACI Anaphylaxis Awareness Day website.

https://eaaci.org/events_meetings/faam-2024/

https://eaaci.org/about-eaaci/

Media Contact:

maria.cubel@eaaci.org
+ 41 44 205 55 39

 

Linkedin banner 1128x191

 

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/c27c467a-b7bf-4bfa-8f57-3cd3111da23b
https://www.globenewswire.com/NewsRoom/AttachmentNg/99c39d50-e140-468f-adbd-7255c9850f7b

05-23 中国物流网:连接世界,智慧物流新篇章
中国物流网:连接世界,智慧物流新篇章
在全球化日益加深的今天,物流行业作为支撑经济发展的重要支柱,正迎 [详细]
08-27 健康中国·基层社区健康管理实践能力高质量发展座谈会在济南召开
健康中国·基层社区健康管理实践能力高质量发展座谈会在济南召开
2024年8月24日,“健康中国·基层社区健康管理实践能力高质量发展 [详细]
04-18 Duck Creek Hosts Annual One Duck Creek Summit to Build Connection, Belonging and Community
Duck Creek Hosts Annual One Duck Creek Summit to Build Connection, Belonging and Community
COLUMBIA, S.C., April 17, 2024 (GLOBE NEWSWIRE) - Today, Duc [详细]
10-21 云顶新耀宣布中国台湾地区药政部门批准全球首个对因治疗IgA肾病药物耐赋康®的新药上市许可申请
云顶新耀宣布中国台湾地区药政部门批准全球首个对因治疗IgA肾病药物耐赋康®的新药上市许可申请
云顶新耀宣布中国台湾地区药政部门批准全球首个对因治疗IgA肾病 [详细]